NCT00403559View on ClinicalTrials.gov

A 4 Week Study of Elidel (Pimecrolimus) for the Treatment of Seborrheic Dermatitis

PHASE2CompletedINTERVENTIONAL

Enrollment

113

Participants

Timeline

Start Date

May 7, 2007

Primary Completion Date

February 20, 2009

Study Completion Date

February 27, 2009

Conditions

Seborrheic Dermatitis

Interventions

DRUG

Elidel

DRUG

Ketoconazole Cream

Trial Locations (1)

40202

Dermatology Specialists, Louisville

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Novartis

INDUSTRY

lead

Dermatology Specialists Research

OTHER